To increase supply, FDA issued special guidelines for chloroquine drugs
In anticipation of increasing market demand for chloroquine phosphate and hydroxychloroquine sulfate, the US Food and Drug Administration (FDA) issued product-specific guidelines for such drugs to support the development of generic drugs and ensure adequate supply.
The FDA's product-specific guidelines for chloroquine phosphate indicate that the drug is rated AA in its "Orange Book"-Approved Drug Products with Therapeutic Equivalence Evaluations, so there are no known or possible bioequivalence issues, and there is no need to Carry out in vivo tests.
At the same time, the product-specific guidelines for hydroxychloroquine sulfate suggest that a bioequivalence exemption can be implemented for the drug based on the Biopharmaceutics Classification System.
2026-10-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Trump Plans 25% Tariffs on Autos, Drugs and Semiconductor Chips
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
Recommend Reading
-
U.S. Imposes 12.5% Additional Tariff! Nutritional Ingredients Including Creatine, Taurine, and Glucosamine Included in New Section 301 Tariff List
-
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
FDA Reopens the Raw Manure Debate
-
FDA Sharpens the Dietary Supplement Ingredient Debate
-
FDA and NIH Launch a New Nutrition Science Partnership
-
Change Rate Remains Positive, This Round of Refined Oil Retail Prices in China Is About to Increase
-
Vendor Shipment Surge Halts Mid-October PC Price Increase
-
Premium Global Chemical Sourcing Requests (3-7 Nov 2025)
-
July China Phenol Market Trended Upward with Fluctuations
-
July China Marine Fuel Market Rises
- Hot Searches
- tirzepatide research peptide for sale online
- polyurethane melting point
- retatrutide glp-3 for sale
- heavy water for sale
- bulk acetic acid
- price acetic acid
- nyquil vs dayquil ingredients
- methanol price per gallon
- where to get reta peptide
- tergitol 91-6
- silicon tetraflouride
- methylene diphenyl diisocyanate sds